Latest Osteoarthritis Stories

Chondromalacia is now being treated at the center for regenerative medicine. "This is a common problem that we treat with regenerative medicine," said Dr. A.J. Farshchian MD. (PRWEB) August 07, 2012 Chondromalacia is now being treated at the center for regenerative medicine. "This is a common problem that we treat with regenerative medicine," said Dr. A.J. Farshchian MD. Chondromalacia patella as well as osteoarthritis are cartilage damages typically producing anterior...

"Advanced Osteoarthritis of the knee is now being treated with regenerative medicine at The Center for Regenerative Medicine," according to Doctor Farshchian an orthopedic regenerative practitioner at the center for regenerative medicine. (PRWEB) July 26, 2012 "Advanced Osteoarthritis of the knee is now being treated with regenerative medicine at The Center for Regenerative Medicine," according to A.J. Farshchian MD an orthopedic regenerative practitioner at the center...

"Obesity a contributing cause of arthritis of the knee is now being treated with regenerative medicine at the Center for Regenerative Medicine." according to Doctor Farshchian an orthopedic regenerative practitioner at the center for regenerative medicine. (PRWEB) July 25, 2012 "Obesity a contributing cause of arthritis of the knee is now being treated with regenerative medicine at the Center for Regenerative Medicine." according to A.J. Farshchian MD an orthopedic...

Cleveland Clinic team simulates cartilage response to loading A Cleveland Clinic research team is developing virtual models of human knee joints to better understand how tissues and their individual cells react to heavy loads – virtual models that someday can be used to understand damage mechanisms caused by the aging process or debilitating diseases, such as osteoarthritis. Led by Ahmet Erdemir, Ph.D., the team is leveraging the powerful computing systems of the Ohio Supercomputer...

SAN FRANCISCO, July 24, 2012 /PRNewswire/ -- Nektar Therapeutics (NASDAQ: NKTR) announced today that the first patient has been enrolled in a Phase 2 clinical study of NKTR-181, a new, first-of-its-kind, opioid analgesic candidate. NKTR-181 is a novel mu-opioid agonist molecule designed to have a slow rate of entry into the brain to reduce the attractiveness of the molecule as a target of abuse and to reduce other CNS-mediated side effects, such as sedation and respiratory depression....

For the nearly 70 million United States residents who suffer with some type of Joint pain, the search for a cure for this ailment or at least some sort of constant relief is a primary concern. Recent discoveries of new-age remedies, medical research as well as a great article posted at Health and Wellness portal BeWellBuzz.com has brought forth cautious optimism that new forms of relief could be on the horizon for nearly one-third of the US population who deal with joint pain on a daily...

MISSISSAUGA, ON, July 23, 2012 /PRNewswire/ - Nuvo Research Inc. (TSX: NRI), a specialty pharmaceutical company dedicated to building a portfolio of products for the topical treatment of pain, today is providing an update on the status of its PENNSAID franchise. PENNSAID (diclofenac sodium topical solution) 1.5% w/w U.S. Patent The United States Patent Office has issued Patent # 8,217,078 relating to a method of using PENNSAID (PENNSAID Patent).  The PENNSAID Patent expiry...

"Knee pain is now being treated with regenerative medicine at The Center for Regenerative Medicine," according to Doctor Farshchian an orthopedic regenerative practitioner at the center for regenerative medicine. (PRWEB) July 22, 2012 "Knee pain is now being treated with regenerative medicine at The Center for Regenerative Medicine," according to A.J. Farshchian MD an orthopedic regenerative practitioner at the center for regenerative medicine. Bowleggedness produces a...

"Degenerative Joint disease of the knee is now being treated with regenerative medicine at he center for regenerative medicine," according to Doctor Farshchian an orthopedic regenerative practitioner at the Center for Regenerative Medicine. (PRWEB) July 21, 2012 "Degenerative Joint disease of the knee is now being treated with regenerative medicine at he center for regenerative medicine," according to A.J. Farshchian MD an orthopedic regenerative practitioner at the...

RealTimeRemedies has launched a new informational review on the product Exomine, an all natural remedy designed to help people suffering from joint pain associated with osteoarthritis. There are many of those with osteoarthritis who want to know if this all natural solution can really give them the relief they are looking for. The answers to this question can be found with the RealTimeRemedies.com review. Houston, TX. (PRWEB) July 19, 2012 For the many people suffering from osteoarthritis...